139 related articles for article (PubMed ID: 24904227)
1. Risk factors for long-term outcome of drug-eluting stenting in adults with early-onset coronary artery disease.
An G; Du Z; Meng X; Guo T; Li G; Chen Y; Li J; An F; Zhang Y; Li W; Zhang C
Int J Med Sci; 2014; 11(7):721-5. PubMed ID: 24904227
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion.
Zhang Y; Wu Z; Wang S; Liu T; Liu J
Cardiovasc Drugs Ther; 2023 Dec; 37(6):1155-1166. PubMed ID: 35930211
[TBL] [Abstract][Full Text] [Related]
4. Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus : Results of the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol- and Zotarolimus-Eluting Stents (ISAR-TEST 5) trial.
Koch T; Lenz T; Joner M; Xhepa E; Koppara T; Wiebe J; Coughlan JJ; Aytekin A; Ibrahim T; Kessler T; Cassese S; Laugwitz KL; Schunkert H; Kastrati A; Kufner S;
Clin Res Cardiol; 2021 Oct; 110(10):1586-1598. PubMed ID: 34156521
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions.
Song PS; Ryu DR; Song YB; Hahn JY; Choi JH; Choi SH; Lee SH; Hong KP; Park JE; Gwon HC
Clin Cardiol; 2011 Jun; 34(6):378-83. PubMed ID: 21538383
[TBL] [Abstract][Full Text] [Related]
6. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.
Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G
Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial).
Jensen LO; Thayssen P; Junker A; Maeng M; Tilsted HH; Kaltoft A; Hansen KN; Christiansen EH; Kristensen SD; Ravkilde J; Madsen M; Sørensen HT; Thuesen L; Lassen JF
Am J Cardiol; 2012 Dec; 110(11):1585-91. PubMed ID: 22959714
[TBL] [Abstract][Full Text] [Related]
9. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).
Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
Lee SW; Chun KJ; Park SW; Kim HS; Kim YH; Yun SC; Kim WJ; Lee JY; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Jon S; Cho YH; Lee NH; Kim JH; Park SJ
Am J Cardiol; 2010 Jan; 105(2):168-73. PubMed ID: 20102913
[TBL] [Abstract][Full Text] [Related]
11. Comparison of restenosis rate with sirolimus-eluting stent in STEMI patients with and without diabetes at 6-month angiographic follow-up.
Ma S; Yang D; Zhang X; Tang B; Li D; Sun M; Yang Y
Acta Cardiol; 2011 Oct; 66(5):603-6. PubMed ID: 22032054
[TBL] [Abstract][Full Text] [Related]
12. Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.
Li X; Kong M; Jiang D; Dong A
Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):347-54. PubMed ID: 24345688
[TBL] [Abstract][Full Text] [Related]
13. Sex difference in long-term clinical outcome after sirolimus-eluting stent implantation.
Trabattoni D; Fabbiocchi F; Galli S; Montorsi P; Lualdi A; Grancini L; Ravagnani P; Bartorelli AL
Coron Artery Dis; 2011; 22(6):442-6. PubMed ID: 21597366
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent.
Xu B; Zhang Q; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Hong T; Li JP; Chen JL; Huo Y; Gao RL; Shen WF
Chin Med J (Engl); 2008 Mar; 121(6):492-7. PubMed ID: 18364131
[TBL] [Abstract][Full Text] [Related]
15. On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes.
Poorhosseini H; Kassaian SE; Aghajani H; Alidoosti M; Hajizeinali AM; Salarifar M; Nematipour E; Amirzadegan AR; Sheikhfathollahi M; Shafiee N; Hakki-Kazazi E; Tokaldany ML
Tex Heart Inst J; 2012; 39(1):24-9. PubMed ID: 22412223
[TBL] [Abstract][Full Text] [Related]
16. Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization.
Kim YG; Park DW; Lee WS; Park GM; Sun BJ; Lee CH; Hwang KW; Cho SW; Kim YR; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Han S; Jung SH; Choo SJ; Chung CH; Lee JW; Park SJ
Am J Cardiol; 2012 Jun; 109(11):1548-57. PubMed ID: 22425329
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical and angiographic results of Sirolimus-Eluting Stent in Complex Coronary Chronic Total Occlusion Revascularization: the SECTOR registry.
Galassi AR; Tomasello SD; Costanzo L; Campisano MB; Barrano G; Tamburino C
J Interv Cardiol; 2011 Oct; 24(5):426-36. PubMed ID: 22004600
[TBL] [Abstract][Full Text] [Related]
18. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
[TBL] [Abstract][Full Text] [Related]
19. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
Kimura T; Morimoto T; Nakagawa Y; Kawai K; Miyazaki S; Muramatsu T; Shiode N; Namura M; Sone T; Oshima S; Nishikawa H; Hiasa Y; Hayashi Y; Nobuyoshi M; Mitudo K;
Circulation; 2012 Jan; 125(4):584-91. PubMed ID: 22203694
[TBL] [Abstract][Full Text] [Related]
20. Impact of sirolimus-eluting and Paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery.
Stankovic G; Cosgrave J; Chieffo A; Iakovou I; Sangiorgi G; Montorfano M; Airoldi F; Carlino M; Michev I; Finci L; Colombo A
Am J Cardiol; 2006 Aug; 98(3):362-6. PubMed ID: 16860024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
